[Federal Register Volume 85, Number 150 (Tuesday, August 4, 2020)]
[Notices]
[Pages 47166-47167]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16887]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-47-2020]


Foreign-Trade Zone (FTZ) 49--Newark and Elizabeth, New Jersey; 
Notification of Proposed Production Activity; Catalent Pharma Solutions 
(Pharmaceutical Products); Somerset, New Jersey

    Catalent Pharma Solutions (Catalent) submitted a notification of 
proposed production activity to the FTZ Board for its facility in 
Somerset, New Jersey. The notification conforming to the requirements 
of the regulations of the FTZ Board (15 CFR 400.22) was received on 
July 17, 2020.
    The applicant indicates that it will be submitting a separate 
application for FTZ designation at the company's facility under FTZ 49. 
The facility is used for the production of encorafenib bulk capsules. 
Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the 
specific foreign-status material and specific finished product 
described in the submitted notification (as described below) and 
subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Catalent from customs 
duty payments on the foreign-status material used in export production. 
On its domestic sales, for the foreign-status material noted below, 
Catalent would be able to choose the duty rate during customs entry 
procedures that applies to BRAFTOVI (encorafenib bulk capsules) (duty-
free). Catalent would be able to avoid duty on foreign-status material

[[Page 47167]]

which becomes scrap/waste. Customs duties also could possibly be 
deferred or reduced on foreign-status production equipment.
    The material sourced from abroad is encorafenib API (duty rate 
6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is September 14, 
2020.
    A copy of the notification will be available for public inspection 
in the ``Reading Room'' section of the Board's website, which is 
accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at 
[email protected] or (202) 482-1963.

    Dated: July 28, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020-16887 Filed 8-3-20; 8:45 am]
BILLING CODE 3510-DS-P